Bioharvest Sciences Inc
CNSX:BHSC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bioharvest Sciences Inc
Income from Continuing Operations
Bioharvest Sciences Inc
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioharvest Sciences Inc
CNSX:BHSC
|
Income from Continuing Operations
-$12.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
High Tide Inc
XTSX:HITI
|
Income from Continuing Operations
-CA$49.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Income from Continuing Operations
-CA$327.3m
|
CAGR 3-Years
53%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
OrganiGram Holdings Inc
TSX:OGI
|
Income from Continuing Operations
CA$18.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Income from Continuing Operations
-CA$15.8m
|
CAGR 3-Years
65%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Income from Continuing Operations
-$2.9m
|
CAGR 3-Years
73%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Bioharvest Sciences Inc
Glance View
BioHarvest Sciences, Inc. develops bio farming technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. The firm operates through two segments: Superfruits and Cannabis. The Superfruits segment is engaged in the development, design, manufacture and marketing of VINIA for the retail market. The Cannabis segment is focused on the development, design, manufacture and marketing of medical cannabis. Its nutraceutical superfruits product, VINIA, is made of red grape (Vitis vinifera) cells grown in the Company's bioreactor facility. The firm is also engaged in research and development of its BioFarming technology for use in the cannabis industry. This plant-based technology produces cannabis cells. The firm is engaged in the sales of VINIA in the Israeli and United States markets. Its subsidiaries include BioHarvest Inc., Dolarin Ltd. (Dolarin) and Superfood Nutraceuticals Inc. (Superfood).
See Also
What is Bioharvest Sciences Inc's Income from Continuing Operations?
Income from Continuing Operations
-12.6m
USD
Based on the financial report for Dec 31, 2023, Bioharvest Sciences Inc's Income from Continuing Operations amounts to -12.6m USD.
What is Bioharvest Sciences Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-24%
Over the last year, the Income from Continuing Operations growth was -12%. The average annual Income from Continuing Operations growth rates for Bioharvest Sciences Inc have been -24% over the past three years .
